Porosome Therapeutics, Inc.

CIK 1934919 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Porosome Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 24, 2026D/A0001376474-26-000247
Jun 3, 2025D/A0001376474-25-000506
Jul 25, 2024D/A0001376474-24-000338
Sep 14, 2023D0001376474-23-000433
Jun 24, 2022D0001376474-22-000299